Triple meeting 2023 – a p53 double-whammy for PMV
Data on PMV’s p53 reactivator prompt a 26% selloff before their presentation, and 48% afterwards.
Data on PMV’s p53 reactivator prompt a 26% selloff before their presentation, and 48% afterwards.
